Montomoli, M.; Roca, L.; Rivera, M.; Fernandez-Prado, R.; Redondo, B.; Camacho, R.; Moyano, C.; Pampa, S.; Gonzalez, A.; Casas, J.;
et al. Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study. Healthcare 2022, 10, 2566.
https://doi.org/10.3390/healthcare10122566
AMA Style
Montomoli M, Roca L, Rivera M, Fernandez-Prado R, Redondo B, Camacho R, Moyano C, Pampa S, Gonzalez A, Casas J,
et al. Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study. Healthcare. 2022; 10(12):2566.
https://doi.org/10.3390/healthcare10122566
Chicago/Turabian Style
Montomoli, Marco, Lourdes Roca, Mariana Rivera, Raul Fernandez-Prado, Beatriz Redondo, Rosa Camacho, Cayetana Moyano, Saul Pampa, Angela Gonzalez, Juan Casas,
and et al. 2022. "Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study" Healthcare 10, no. 12: 2566.
https://doi.org/10.3390/healthcare10122566
APA Style
Montomoli, M., Roca, L., Rivera, M., Fernandez-Prado, R., Redondo, B., Camacho, R., Moyano, C., Pampa, S., Gonzalez, A., Casas, J., Kislikova, M., Sanchez Horrillo, A., Cabrera Cárdena, A., Quiroga, B., Rabasco, C., Piqueras, S., Suso, A., Reque, J., Villa, J.,
... Arroyo, D.
(2022). Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study. Healthcare, 10(12), 2566.
https://doi.org/10.3390/healthcare10122566
